D
CASI Pharmaceuticals, Inc. CASI
$0.94 $0.010.88% NASDAQ
Recommendation
Prev Close
$0.93
Volume
21,905
Avg Vol (90D)
917,887
Market Cap
$19.15M
Dividend & Yield
--
52-Week Range
$0.93 - $4.05
P/E (TTM)
--
EPS (TTM)
-$2.12
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Lacklustre Performance Is Driving CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) 27% Price Drop
11/25/2025 - Simply Wall St
CASI Pharmaceuticals Announces Changes in Board Governance
11/19/2025 - GuruFocus
Casi Pharmaceuticals appoints James Huang as non-executive chairman
11/19/2025 - TipRanks Financial Blog
Casi Pharmaceuticals appoints James Huang as non-executive chairman
11/19/2025 - The Fly
CASI Pharmaceuticals Announces Changes in Board Governance
11/19/2025 - ACCESS Newswire
CASI Pharmaceuticals Announces Third Quarter 2025 Business and Financial Results
11/15/2025 - GuruFocus
CASI Pharmaceuticals Announces Third Quarter 2025 Business and Financial Results
11/14/2025 - ACCESS Newswire
CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ
11/11/2025 - GuruFocus
CASI Pharmaceuticals appeals NASDAQ delisting determination
11/10/2025 - Seeking Alpha - Healthcare
CASI Pharmaceuticals Receives and Appeals Delisting Determination from NASDAQ
11/10/2025 - ACCESS Newswire
CASI Pharmaceuticals to Participate at Guggenheim Healthcare Innovation Conference
11/4/2025 - GuruFocus
CASI Pharmaceuticals to Participate at Guggenheim Healthcare Innovation Conference
11/4/2025 - ACCESS Newswire
CASI Pharmaceuticals Announces Upcoming Presentation of Clinical Results for CID-103 at the ...
11/3/2025 - GuruFocus
CASI Pharmaceuticals Announces Upcoming Presentation of Clinical Results for CID-103 at the 67th American Society of Hematology (ASH) Annual Meeting
11/3/2025 - ACCESS Newswire
CASI Pharmaceuticals Advances CID-103 in Promising ITP Study
10/27/2025 - TipRanks Financial Blog
CASI Pharmaceuticals (NASDAQ:CASI) & Evotec (NASDAQ:EVO) Critical Analysis
10/10/2025 - Ticker Report
Little Excitement Around CASI Pharmaceuticals, Inc.'s (NASDAQ:CASI) Revenues As Shares Take 43% Pounding
9/30/2025 - Simply Wall St
CASI Pharmaceuticals Appoints James Huang to Board of Directors
9/26/2025 - GuruFocus
Casi Pharmaceuticals appoints James Hunag to board of directors
9/26/2025 - TipRanks Financial Blog
Casi Pharmaceuticals appoints James Hunag to board of directors
9/26/2025 - The Fly
CASI Pharmaceuticals Strengthens Board with Industry Veteran James Huang
9/26/2025 - TipRanks Financial Blog
CASI Pharmaceuticals Appoints James Huang to Board of Directors
9/26/2025 - ACCESS Newswire
One CASI Pharmaceuticals, Inc. (NASDAQ:CASI) Analyst Just Made A Major Cut To Next Year's Estimates
9/9/2025 - Simply Wall St
CASI Pharmaceuticals Announces Safety Monitoring Committee Recommendation to Escalate CID-103 ...
9/8/2025 - GuruFocus
CASI Pharmaceuticals Announces Safety Monitoring Committee Recommendation to Escalate CID-103 ...
9/8/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
$24.46M
Total Debt (Q)
$18.86M
Total Liabilities (Q)
$53.05M
Book Value Per Share (Q)
-$1.39
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Friday, November 14, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Dec 15 and 19 (est)
Price History
Loading...
Beta
1.13
7-Day Total Return
-23.58%
30-Day Total Return
-45.03%
60-Day Total Return
-59.83%
90-Day Total Return
-41.98%
Year to Date Total Return
-68.46%
1-Year Total Return
-73.67%
2-Year Total Return
-84.12%
3-Year Total Return
-51.55%
5-Year Total Return
-96.05%
52-week Low
Dec 02, 2025 - $0.93
52-week High
Dec 03, 2024 - $4.05
Valuation
Market Cap
$19.15M - Nano Cap
Enterprise Value
$33.32M
Price/Sales (TTM)
0.66
Price/Book (Q)
-0.67
Dividends and Shares
Shares Outstanding
16.05
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.casipharmaceuticals.com
Phone Number
86 10 6508 6063
Address
1701-1702, China Central Office Tower 1
No. 81 Jianguo Road - Chaoyang District
Beijing, 100025
Country
China
Year Founded
1991
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People’s Republic of China, the United States, and... more
NASDAQ 12/03/2025 4:00PM Eastern Quotes delayed